Vroman Ken
- SEC CIK
- 0001429863
In the past year, 1 open-market sale filing worth $1.59M and no purchases.
Current role at each company
- CME CME Group Inc.Chief Transformation Officeras of Sep 17, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.59M
- 1 filing
- Net
- −$1.59M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Vroman Ken as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2026 (view filing) | Mar 12 | Same day | Vroman KenChief Transformation Officer | SSaleCommon Stock Class A | −5.16K | $309.00 | −$1.59M | −25.7%14.9K after | |
| Feb 14, 2025 (view filing) | Feb 13 | 1 day | Vroman KenChief Transformation Officer | SSaleCommon Stock Class A | −5.07K | $250.00 | −$1.27M | −23.3%16.7K after | |
| Sep 13, 2022 (view filing) | Sep 12 | 1 day | Vroman KenChief Transformation Officer | SSaleCommon Stock Class A | −750 | $201.41 | −$151.1K | −5.7%12.5K after | |
| Nov 12, 2021 (view filing) | Nov 9 | 3 days | Vroman KenSr MD International & Optimiza | SSaleCommon Stock Class A | −445 | $220.00 | −$97.9K | −3.3%13.1K after |